Therapy of hyperlipidemic states.
D002791:Cholesterol, Dietary / Q000008:administration & dosage; D002792:Cholestyramine Resin / Q000627:therapeutic use; D002994:Clofibrate / Q000627:therapeutic use; D003084:Colestipol / Q000627:therapeutic use; D004041:Dietary Fats / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D006801:Humans; D006949:Hyperlipidemias / Q000235:genetics / Q000628:therapy*; D006938:Hyperlipoproteinemia Type II / Q000628:therapy; D006953:Hyperlipoproteinemia Type IV / Q000628:therapy; D008077:Lipoproteins, LDL / Q000097:blood; D008079:Lipoproteins, VLDL / Q000097:blood; D009525:Niacin; D009539:Nicotinic Acids / Q000627:therapeutic use; D012855:Sitosterols / Q000627:therapeutic use
D002791:Cholesterol, Dietary; D004041:Dietary Fats; D008077:Lipoproteins, LDL; D008079:Lipoproteins, VLDL; D009539:Nicotinic Acids; D012855:Sitosterols; D002792:Cholestyramine Resin; D009525:Niacin; C025473:gamma-sitosterol; D002994:Clofibrate; D003084:Colestipol